News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
859,406 Results
Type
Article (87333)
Company Profile (759)
Press Release (771289)
Multimedia
Podcasts (167)
Webinars (27)
Section
Business (233015)
Career Advice (4137)
Deals (39785)
Drug Delivery (133)
Drug Development (91228)
Employer Resources (202)
FDA (18266)
Job Trends (17393)
News (397294)
Policy (39914)
Tag
Academia (3003)
Academic (2)
Accelerated approval (17)
Adcomms (35)
Allergies (123)
Alliances (56979)
ALS (139)
Alzheimer's disease (1668)
Antibody-drug conjugate (ADC) (217)
Approvals (18271)
Artificial intelligence (469)
Autoimmune disease (61)
Automation (25)
Bankruptcy (406)
Best Places to Work (12633)
BIOSECURE Act (22)
Biosimilars (157)
Biotechnology (484)
Bladder cancer (121)
Brain cancer (49)
Breast cancer (464)
Cancer (3700)
Cardiovascular disease (328)
Career advice (3552)
Career pathing (37)
CAR-T (237)
CDC (52)
Cell therapy (650)
Cervical cancer (32)
Clinical research (75143)
Collaboration (1332)
Company closure (4)
Compensation (888)
Complete response letters (59)
COVID-19 (2946)
CRISPR (80)
C-suite (545)
Cystic fibrosis (132)
Data (4051)
Decentralized trials (2)
Denatured (59)
Depression (106)
Diabetes (440)
Diagnostics (7074)
Digital health (32)
Diversity (11)
Diversity, equity & inclusion (49)
Drug discovery (226)
Drug pricing (175)
Drug shortages (36)
Duchenne muscular dystrophy (191)
Earnings (98691)
Editorial (54)
Employer branding (25)
Employer resources (171)
Events (132600)
Executive appointments (968)
FDA (20611)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (5)
Frontotemporal dementia (12)
Funding (1196)
Gene editing (167)
Generative AI (45)
Gene therapy (513)
GLP-1 (1007)
Government (5367)
Grass and pollen (7)
Guidances (335)
Healthcare (20937)
HIV (48)
Huntington's disease (36)
IgA nephropathy (55)
Immunology and inflammation (237)
Immuno-oncology (19)
Indications (51)
Infectious disease (3175)
Inflammatory bowel disease (180)
Inflation Reduction Act (14)
Influenza (91)
Intellectual property (179)
Interviews (815)
IPO (17923)
IRA (59)
Job creations (5196)
Job search strategy (2864)
Kidney cancer (15)
Labor market (74)
Layoffs (634)
Leadership (31)
Legal (10148)
Liver cancer (91)
Longevity (12)
Lung cancer (528)
Lymphoma (255)
Machine learning (26)
Management (66)
Manufacturing (604)
MASH (129)
Medical device (14852)
Medtech (14872)
Mergers & acquisitions (22708)
Metabolic disorders (1120)
Multiple sclerosis (132)
NASH (23)
Neurodegenerative disease (208)
Neuropsychiatric disorders (56)
Neuroscience (2640)
NextGen: Class of 2025 (7687)
Non-profit (5095)
Now hiring (55)
Obesity (551)
Opinion (307)
Ovarian cancer (122)
Pain (160)
Pancreatic cancer (163)
Parkinson's disease (227)
Partnered (28)
Patents (401)
Patient recruitment (291)
Peanut (57)
People (66157)
Pharmaceutical (144)
Pharmacy benefit managers (26)
Phase I (23163)
Phase II (32633)
Phase III (24553)
Pipeline (2588)
Policy (288)
Postmarket research (3554)
Preclinical (10456)
Press Release (72)
Prostate cancer (187)
Psychedelics (51)
Radiopharmaceuticals (281)
Rare diseases (636)
Real estate (7420)
Recruiting (78)
Regulatory (27857)
Reports (64)
Research institute (2684)
Resumes & cover letters (650)
Rett syndrome (12)
RNA editing (15)
RSV (69)
Schizophrenia (126)
Series A (198)
Series B (147)
Service/supplier (30)
Sickle cell disease (78)
Special edition (25)
Spinal muscular atrophy (170)
Sponsored (40)
Startups (4318)
State (2)
Stomach cancer (17)
Supply chain (98)
Tariffs (88)
The Weekly (106)
Vaccines (1025)
Venture capital (66)
Weight loss (385)
Women's health (57)
Worklife (21)
Date
Today (149)
Last 7 days (608)
Last 30 days (2623)
Last 365 days (33753)
2025 (24945)
2024 (38139)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1278)
Alabama (79)
Alaska (7)
Arizona (299)
Arkansas (14)
Asia (50873)
Australia (8936)
California (9135)
Canada (2786)
China (862)
Colorado (388)
Connecticut (408)
Delaware (251)
Europe (116880)
Florida (1344)
Georgia (308)
Hawaii (3)
Idaho (67)
Illinois (799)
India (47)
Indiana (446)
Iowa (19)
Japan (298)
Kansas (123)
Kentucky (36)
Louisiana (20)
Maine (76)
Maryland (1241)
Massachusetts (6878)
Michigan (305)
Minnesota (552)
Mississippi (4)
Missouri (115)
Montana (33)
Nebraska (26)
Nevada (106)
New Hampshire (76)
New Jersey (2536)
New Mexico (32)
New York (2499)
North Carolina (1384)
North Dakota (10)
Northern California (4080)
Ohio (286)
Oklahoma (20)
Oregon (50)
Pennsylvania (1906)
Puerto Rico (19)
Rhode Island (46)
South America (1655)
South Carolina (46)
South Dakota (1)
Southern California (3492)
Tennessee (148)
Texas (1428)
United States (33893)
Utah (272)
Virginia (242)
Washington D.C. (82)
Washington State (789)
West Virginia (4)
Wisconsin (95)
Wyoming (1)
There are 859,406 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
ZYUS Life Sciences Announces Activation of Two Additional Clinical Sites in Phase 2a UTOPIA-1 Cancer Pain Trial
October 2, 2025
·
4 min read
Press Releases
OncoC4 Closes Nearly $50 Million in Series B Financing to Advance Multiple Pipeline Candidates
October 2, 2025
·
1 min read
Cell therapy
Takeda Exits Cell Therapy Amid Strategic Pivot, Dealing Blow to Once Promising Modality
Takeda is looking to offload its cell therapy platform and preclinical assets to a yet-unidentified external partner. 137 employees will be let go as part of the move.
October 2, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Sitryx receives FDA clearance of IND application for SYX-5219 for the treatment of atopic dermatitis
October 2, 2025
·
3 min read
Press Releases
Daiichi Sankyo Establishes Third Research Institute in San Diego
October 2, 2025
·
1 min read
Press Releases
PepGen Announces Oral Presentations at the 30th Annual International Congress of the World Muscle Society
October 2, 2025
·
2 min read
Press Releases
Key Milestone in ACTIVATE Phase 2 Clinical Trial of BIA 28-6156
October 2, 2025
·
3 min read
Press Releases
Sobi Selects Kinaxis to Accelerate Access to Life-Changing Treatments
October 2, 2025
·
2 min read
Press Releases
Newron to Present New Analyses From and Updates on its Clinical Program Evaluating Evenamide as an Add-on Treatment for Schizophrenia at the 38th European College of Neuropsychopharmacology (ECNP) Congress 2025
October 2, 2025
·
8 min read
Press Releases
KalVista Pharmaceuticals Announces Appointment of Bethany L. Sensenig to Board of Directors
October 2, 2025
·
4 min read
1 of 85,941
Next
